Long-acting PEG-rhG-CSF Market Size to Reach USD 5.53 Billion by 2032: 6.8% CAGR Driven by Chemotherapy-Induced Neutropenia Management & Biosimilar Expansion — Exclusive Market Report

クレジット

金金

インタビューワー